Ignite Creation Date:
2025-12-25 @ 12:38 AM
Ignite Modification Date:
2026-01-05 @ 2:52 PM
Study NCT ID:
NCT00093067
Status:
COMPLETED
Last Update Posted:
2017-02-13
First Post:
2004-09-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Daptomycin in the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to S. Aureus
Sponsor:
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-03
Start Date Type:
None
Primary Completion Date:
2004-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-02
Completion Date Type:
ACTUAL
First Submit Date:
2004-09-30
First Submit QC Date:
None
Study First Post Date:
2004-10-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-02-09
Last Update Post Date:
2017-02-13
Last Update Post Date Type:
ACTUAL